The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis
Open accessAbstract
Oxidative stress has been suggested to play a key role in Parkinson's disease, but inconsistent results were found in clinical studies. This study sought to quantitatively summarize the blood and cerebrospinal fluid (CSF) oxidative stress marker data in PD patients. We performed a systematic search of PubMed and Web of Science, and studies were included if they provided data on peripheral blood and CSF oxidative stress marker concentrations in PD patients and healthy control (HC) subjects. Data were extracted by three independent investigators from 80 included studies encompassing 7,212 PD patients and 6,037 HC subjects. Of the 22 oxidative stress markers analyzed, random effects meta-analysis showed that blood concentrations of 8-OhdG, MDA, nitrite, and ferritin were increased in patients with PD compared with HC subjects. In contrast, we showed that blood levels of catalase, uric acid, glutathione, and total-cholesterol were significantly down-regulated in patients with PD when compared with controls. There were no significant differences between PD patients and HC subjects for blood, Mn, Cu, Zn, Fe, SOD, albumin, glutathione peroxidase, vitamin E, ceruloplasmin, triglycerides, lactoferrin, transferrin, LDL-cholesterol, and HDL-cholesterol. Due to the limited number of CSF studies with small sample size, this meta-analysis only showed non-significant association between CSF 8-OhdG and PD. The findings of our meta-analysis demonstrated higher blood concentrations of 8-OhdG, MDA, nitrite and ferritin, and lower blood concentrations of catalase, uric acid, glutathione and total-cholesterol in PD patients, strengthening the clinical evidence that PD is accompanied by increased oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
Qin, X.-Y., Zhang, S.-P., Cao, C., Loh, Y. P., & Cheng, Y. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2742 · Cited by 554
Self-citationMeta-analysis of oxidative stress in schizophrenia.
Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491
A Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 474
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis
Schrag, M., Mueller, C., Zabel, M., Crofton, A., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 336
Niranjan, R. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8483-x · Cited by 327
Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
Gaki, G. S., & Papavassiliou, A. G. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8294-x · Cited by 200
Parkinson’s disease and enhanced inflammatory response
Stojkovska, I., Wagner, B. M., & Morrison, B. E. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215576313 · Cited by 152
Andreadou, E., Nikolaou, C., Gournaras, F., Rentzos, M., Boufidou, F., Tsoutsou, A., Zournas, C., Zissimopoulos, V., & Vassilopoulos, D. (2009) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.06.012 · Cited by 147
Qin, X.-Y., Cao, C., Cawley, N. X., Liu, T.-T., Yuan, J., Loh, Y. P., & Cheng, Y. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.62 · Cited by 142
Self-citationIncreased oxidative damage in peripheral blood correlates with severity of Parkinson's disease
Chen, C., Liu, J., Wu, Y., Chen, Y., Cheng, H., Cheng, M., & Chiu, D. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.011 · Cited by 136
Iron and Oxidative Stress in Parkinson’s Disease: An Observational Study of Injury Biomarkers
Medeiros, M. S., Schumacher-Schuh, A., Cardoso, A. M., Bochi, G. V., Baldissarelli, J., Kegler, A., Santana, D., Chaves, C. M. M. B. S., Schetinger, M. R. C., Moresco, R. N., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146129 · Cited by 131
Alimonti, A., Ristori, G., Giubilei, F., Stazi, M. A., Pino, A., Visconti, A., Brescianini, S., Monti, M. S., Forte, G., Stanzione, P., et al. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.12.001 · Cited by 128
Bhimani, R. (2014) · Rehabilitation Research and Practice · doi:10.1155/2014/718527 · Cited by 125
Parkinson’s disease: experimental models and reality
Jiang, P., & Dickson, D. W. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1788-5 · Cited by 121
Parkinson’s disease: oxidative stress and therapeutic approaches
Surendran, S., & Rajasankar, S. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0245-1 · Cited by 113
Qin, X., Feng, J., Cao, C. Q., Wu, H., Loh, Y. P., & Cheng, Y. (2016) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2016.1626 · Cited by 113
Self-citationA meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia
Qin, X.-Y., Wu, H., Cao, C., Loh, Y. P., & Cheng, Y. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.235 · Cited by 85
Self-citationÇokal, B. G., Yurtdaş, M., Güler, S. K., Güneş, H. N., Uçar, C. A., Aytaç, B., Durak, İ., Yoldaş, T. K., Durak, İ., & Çubukçu, H. C. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2782-8 · Cited by 65
Serum antioxidant enzyme activity in Parkinson's disease
Kalra, J., Rajput, A. H., Mantha, S. V., et al. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf02454194 · Cited by 53
Sleep and non-motor symptoms in Parkinson’s disease
Maass, A., & Reichmann, H. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-0966-4 · Cited by 49
Altered oxidative stress levels in Indian Parkinson's disease patients with PARK2 mutations.
Vinish, M., Anand, A., & Prabhakar, S. K. (2011) · Acta Biochimica Polonica · doi:10.18388/abp.2011_2260 · Cited by 42
Low serum uric acid concentration in Parkinson's disease in southern Spain
Jesús, S., Pérez, I. M., Cáceres‐Redondo, M. T., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03745.x · Cited by 39
Cited by
Pisoschi, A. M., Pop, A., Iordache, F., Stanca, L., Predoi, G., & Serban, A. I. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112891 · Cited by 816
NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Brandes, M. S., & Gray, N. E. (2020) · ASN Neuro · doi:10.1177/1759091419899782 · Cited by 297
The Glutathione System in Parkinson’s Disease and Its Progression
Bjørklund, G., Peana, M., Maes, M., Dadar, M., & Severin, B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.004 · Cited by 186
Saha, S., Buttari, B., Profumo, E., Tucci, P., & Saso, L. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.787258 · Cited by 185
Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System
Malik, A. R., & Willnow, T. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225671 · Cited by 170
Metadata
- Authors
- Wei, Z., Li, X., Li, X., Liu, Q., & Cheng, Y.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-07-05
- Volume
- 11
- Pages
- 236-236
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2861203326
- Cited by
- 281
- References
- 30
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.